INVEGA HAFYERA

Janssen Pharmaceuticals, Inc🇺🇸 United States

FDA Page

Effective Date: Oct 27, 2021
Approval ID: 6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b
Products: 2 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INVEGA HAFYERA safely and effectively. See full prescribing information for INVEGA HAFYERA. INVEGA HAFYERA™ (paliperidone palmitate) extended-release injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 2006

Quick Stats

Total Products2

Labelers2

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.